钜泉科技(688391) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was ¥121,389,924.86, a decrease of 3.86% compared to ¥126,259,159.11 in the same period last year[4] - Net profit attributable to shareholders decreased by 53.45% to ¥8,937,596.36 from ¥19,199,667.05 year-on-year[4] - Basic and diluted earnings per share both dropped by 50.00% to ¥0.08 from ¥0.16 year-on-year[4] - Total operating revenue for Q1 2025 was CNY 121,389,924.86, a decrease of 3.46% compared to CNY 126,259,159.11 in Q1 2024[14] - Net profit for Q1 2025 was CNY 8,937,596.36, down 53.4% from CNY 19,199,667.05 in Q1 2024[16] Cash Flow - The net cash flow from operating activities was negative at -¥32,582,722.88, a decline of 401.39% compared to ¥10,810,791.64 in the previous year[4] - Operating cash flow for Q1 2025 was negative at CNY -32,582,722.88, compared to a positive CNY 10,810,791.64 in Q1 2024[18] - Cash inflow from operating activities totaled CNY 126,032,208.50, down from CNY 141,654,349.03 in the previous year[18] - Net cash flow from investment activities was -5,735,128.94, a decrease compared to 103,674,844.33 from the previous period[19] - Cash inflow from financing activities was 705,600.97, with no cash received from other financing activities in the previous period[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,003,760,175.68, a decrease of 0.64% from ¥2,016,675,466.61 at the end of the previous year[5] - The total liabilities as of March 31, 2025, included accounts payable of CNY 75,032,769.50, slightly up from CNY 74,784,269.28, showing a marginal increase[12] - Total liabilities decreased to CNY 124,827,143.47 from CNY 148,634,830.76 year-over-year[13] - Total equity attributable to shareholders increased to CNY 1,878,933,032.21 from CNY 1,868,040,635.85[13] Research and Development - R&D investment totaled ¥43,687,758.75, an increase of 12.38% from ¥38,875,962.37 in the previous year, representing 35.99% of operating revenue, up by 5.2 percentage points[5] - Research and development expenses rose to CNY 43,687,758.75, an increase of 12.5% from CNY 38,875,962.37 in the same quarter last year[14] - The company experienced a significant decline in net profit due to reduced product prices and changes in product structure, alongside increased R&D expenditures[7] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 7,300[9] Other Notable Information - The company has not reported any significant changes in the shareholding structure or any new financing activities during the reporting period[10] - There were no new product launches or technological advancements mentioned in the conference call[10] - The company did not provide specific guidance for future performance or market expansion strategies during the call[10] - No significant mergers or acquisitions were discussed in the earnings call[10] - The company will not apply new accounting standards starting from 2025[19] - The company is led by Yang Shicong, with accounting responsibilities held by Diao Fengzhi and Xu Rong[19]